Interleukin-2 Receptor Blocking Antibody [EPC] - N0000175622
Pharmacologic Class Information
Pharmacologic Code | N0000175622 |
Pharmacologic Name | Interleukin-2 Receptor Blocking Antibody |
Pharmacologic Uses |
|
Pharmacologic Concept | Established Pharmacologic Classes - [EPC] |
Pharmacologic Concept Description | An established pharmacologic class is a term or phrase that is scientifically valid
and clinically meaningful according to the following definitions:
|
NDC Products with Interleukin-2 Receptor Blocking Antibody
The table contains 2 products whose active ingredient are classified under the same pharmacologic class Interleukin-2 Receptor Blocking Antibody [EPC].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0078-0331 | Simulect | Non-Proprietary Name: Basiliximab | Injection, Powder, For Solution | Intravenous | Novartis Pharmaceuticals Corporation | ACTIVE | |
0078-0393 | Simulect | Non-Proprietary Name: Basiliximab | Injection, Powder, For Solution | Intravenous | Novartis Pharmaceuticals Corporation | ACTIVE |